PROTAC CYP1B1 degrader-1

Overview

PROTAC CYP1B1 degrader-1 is a CYP1B1 PROTAC degrader with a human IC 50 of 95.1 nM. PROTAC CYP1B1 degrader-1 induces concentration-dependent CYP1B1 degradation. PROTAC CYP1B1 degrader-1 can be used for the research of CYP1B1 -mediated Docetaxel ( HY-B0011 )-resistant prostate cancer . (Pink: CYP1B1 Target protein ligand; Blue: Cereblon ligand ( HY-103596 ); Black: linker).

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > PROTACs | Products > Signaling Pathways > Cytochrome P450

Product Information

• Catalog No.: HY-146393
• CAS No.: 2411389-67-6
• Molecular Formula: C43H39N5O10
• Molecular Weight: 785.80
• Purity: 98.09%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Availability: In-stock

Source

Original product source